₩4,370-0.46%
2026-10-07 closeVaxcell-Bio Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was KRW 1.9B. 2024 operating profit was −KRW 15.05B.
Reported results
Quantus Signal · live data · not investment advice · Privacy Policy